돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 455922생성일: 2026년 10월 25일

Pipemidic Acid → 2-(4-{[(3-Benzothiadiazolphenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic Acid

https://huagongshe.com/reaction/455922

반응식

참여 물질

역할이름HCID투입량
반응물Pipemidic AcidHCID 4831—
반응물TriethylamineHCID 8471—
반응물2,1,3-Benzothiadiazol-5-yl isothiocyanateHCID 2776292—
생성물2-(4-{[(3-Benzothiadiazolphenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic AcidHCID 45484169—

반응 단계

Pipemidic acid (25 mg, 0.0824 mmol), 2,1,3-benzothiadiazol-5-yl isothiocyanate (15.8 mg, 0.0824 mmol) and triethylamine (23 μL, 0.165 mmol) were used. Purification on silica yielded compound 7 in Table 1, below (24 mg, 58%). 1H NMR (300 MHz, DMSO) δ 9.26 (s, 1H), 8.98 (s, 1H), 7.98-7.82 (m, 3H), 4.51-4.33 (m, 2H), 4.24-3.99 (m, 8H), 1.42-1.32 (m, 3H) ppm.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08497371B2
출처 데이터셋uspto-grants-2013_07
ORD IDord-1055adf2670945d680d887e10525002d
출처 메모uspto-grants-2013_07